Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn

Simple item page
dc.contributor.authorDerek de Winter
dc.contributor.authorE. J. T. Verweij
dc.contributor.authorAnne Debeer
dc.contributor.authorRoland Devlieger
dc.contributor.authorLiesbeth Lewi
dc.contributor.authorSarah Verbeeck
dc.contributor.authorP Maurice
dc.contributor.authorJean‐Marie Jouannic
dc.contributor.authorMarie-Gabrielle Guillemin
dc.contributor.authorAgnès Mailloux
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:22:11Z
dc.date.available2026-03-22T14:22:11Z
dc.date.issued2025
dc.descriptionCitaciones: 9
dc.description.abstractIn this cohort study of neonates with HDFN managed at 31 centers in 22 countries, significant practice variations in the postnatal management of HDFN were identified, highlighting the lack of, and need for, consensus. The study suggests that there is a potential beneficial clinical association of waiting for delivery until after 37 weeks and 0 days with frequency of exchange transfusions among neonates with HDFN. The framework to implement international guidelines is provided.
dc.identifier.doi10.1001/jamanetworkopen.2024.54330
dc.identifier.urihttps://doi.org/10.1001/jamanetworkopen.2024.54330
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/46109
dc.language.isoen
dc.publisherAmerican Medical Association
dc.relation.ispartofJAMA Network Open
dc.sourceLeiden University Medical Center
dc.subjectFetus
dc.subjectHemolytic disease of the newborn (ABO)
dc.subjectDisease
dc.subjectMedicine
dc.subjectPregnancy
dc.titleVariations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn
dc.typearticle

Files

Collections

Artículo Científico Publicado